Why the study?
Is visit-to-visit blood pressure variability associated with cardiovascular death in elderly patients with systolic hypertension?
Observational (n=4,736)
Double-blind
Yes
Is visit-to-visit blood pressure variability associated with cardiovascular death in elderly patients with systolic hypertension?
Visit-to-visit blood pressure variability is associated with long-term cardiovascular mortality in elderly patients with systolic hypertension, particularly among those receiving active antihypertensive treatment.
Answers are grounded in this paper and cite their sources.
Associated with higher long-term CV mortality in treated elderly hypertensives; hypothesis-generating, prospective trials needed before practice change.
Most studies of an association of visit-to-visit variability of blood pressure with increased risk of future adverse cardiovascular events are of short duration and rarely include a placebo group. Using data from the double-blind, placebo-controlled Systolic Hypertension in the Elderly Program, the authors examined mortality from cardiovascular causes up to 17 years of follow-up using the National Death Index. Visit-to-visit blood pressure variability was associated with cardiovascular death after adjustment for sex, age, serum creatinine, diabetes, body mass index, smoking status, left ventricular failure, and high-density lipoprotein cholesterol. The relationship was significantly stronger in the active treatment group compared with the placebo group. Although this could be the result of an effect of the medications used unrelated to visit-to-visit variability, the data are compatible with the hypothesis that inconsistent adherence leading to missing active medication doses may be an additional explanation for the relationship of visit-to-visit variability with cardiovascular death.
No takes yet. Share an insight, caveat, or question.
Kostis et al. (2013) conducted an observational in Isolated systolic hypertension (n=4,736). Visit-to-visit blood pressure variability vs. Lower visit-to-visit blood pressure variability was evaluated on Cardiovascular death (HR 1.0049, 95% CI 1.0001-1.01, p=0.044).
Synapse has enriched 10 related papers. Consider them for comparative context: